De definitieve gids voor genbewerking.
★
Menu
Home Leren Nieuws
Verkennen Technologieën Ziekten Behandelingen Klinische onderzoeken Bedrijven Wetenschappers Genen Onderzoek Instellingen
Verder dan geneeskunde Landbouw Ethiek Investeren Wereldkaart
Leren & Tools Begin hier Woordenlijst A–Z Vergelijk technologieën Tijdlijn Lijsten & Rankings AI-agents ★ Opgeslagen API
Over Over ons Methodologie Databronnen Redactioneel beleid Contact Disclaimers

Begeleide weergave
Nieuw in de genetica? We leggen elk begrip uit terwijl je bladert, in gewone taal. Dezelfde pagina's, met de hulp ingebouwd.

Expertvisie
Je kent de biologie al. Alleen de inhoud, helder en compact, zonder extra uitleg. Dit is de standaardweergave.

Interfacetaal
Lichte modus
Two molecular structures side by side, linked by threads of light

Hulpmiddel

Vergelijk technologieën

Kies twee of drie benaderingen en zie hoe ze van elkaar verschillen op precisie, DNA-knippen, cargo-omvang, toediening, klinische volwassenheid en bekende risico's.

Kies hierboven twee technologieën, of lees een van de geschreven vergelijkingen hieronder.

Geschreven vergelijkingen

De onderscheidingen die mensen het vaakst verkeerd begrijpen, goed uitgelegd.

Alle technologieën

Open de database →
the crystal structure of Streptococcus pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5 A ˚ resolution CRISPR-Cas9A protein that can be programmed with a short RNA guide to find one specific sequence in a genome and cut it. Approved A DNA helix with one letter being chemically changed Base EditingChemically converts one DNA letter into another at a chosen position, without cutting both strands of the double helix. Phase III A prime editor writing new letters into a DNA strand Prime EditingWrites a new stretch of DNA sequence directly into a chosen site, using a guide that carries the replacement text with it. Phase I/II A Cas12 enzyme on DNA, scattering fragments CRISPR-Cas12A family of CRISPR nucleases that cut DNA leaving staggered ends, use a different sequence requirement from Cas9, and can be smaller. Phase I/II A Cas13 enzyme cutting a strand of RNA CRISPR-Cas13Targets RNA rather than DNA, so it can silence a gene's message without touching the genome itself. Phase I A tiny Cas14 enzyme bound to a DNA helix Cas14 and miniature Cas systemsUnusually small CRISPR nucleases, roughly a third the size of Cas9, discovered in archaea and bacteriophages. Discovery An enzyme changing a letter on a strand of RNA RNA EditingChanges letters in the RNA message rather than in the DNA, so the effect is real but temporary and the genome is untouched. Phase I/II A DNA helix studded with glowing chemical tags Epigenetic EditingChanges how loudly a gene is expressed by rewriting the chemical marks on and around it, without altering a single letter of DNA sequence. Preclinical A deactivated Cas9 on DNA beaming light to switch a gene on CRISPRa (gene activation)Uses a disabled CRISPR protein to switch a gene up rather than to cut it. Research tool A deactivated Cas9 sitting on a DNA strand, blocking it CRISPRi (gene silencing)Parks a disabled CRISPR protein on a gene to block it from being read, turning it down without changing it. Research tool TALEN protein arms gripping a DNA helix TALENsCustom-built proteins that recognise DNA letter by letter and cut: the technique CRISPR largely displaced, still in clinical use. Phase I/II Zinc finger proteins binding along a DNA helix Zinc Finger NucleasesThe first programmable gene-editing tool to reach patients: small, engineered proteins that grip DNA in three-letter blocks. Phase III A recombinase enzyme swapping DNA segments Recombinases and integrasesEnzymes that cut and rejoin DNA at defined sites, able to insert whole genes rather than edit single letters. Preclinical A transposase moving a DNA segment to a new place TransposasesEnzymes that cut a segment of DNA out of one place and paste it into another: nature's own copy-and-paste. Phase I/II A viral capsid delivering a gene into a cell Gene Therapy (gene addition)Delivers a working copy of a gene into cells without changing the existing genome. It is the older approach that gene editing is often confused with. Approved An RNA-guided complex unwinding a strand of RNA RNA InterferenceUses the cell's own machinery to destroy a specific RNA message, lowering a protein's level without touching DNA. Approved Modular components being assembled on a bench Synthetic BiologyDesigning genetic parts and circuits so that cells perform new functions: the engineering discipline that gene editing serves as a tool. Phase III